COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is pleased to announce the Company has published an article on HIV Haven (www.hivhaven.com), a dynamic international HIV community website. The article entitled “Cannabinoid Research Shows Promise for HIV TAT Inhibition” is written by Dr. Robert Melamede, Ph.D., President of Cannabis Science Inc., and Dr. David Miller, Ph.D., an AIDS treatment activist.
